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Abstract 
Poly (d,l-lactic-co-glycolic) acid (PLGA) based microspheres have been extensively 
used as controlled drug release systems. However, the burst effect has been a 
persistent issue associated with such systems, especially for those prepared by the 
double emulsion technique. An effective approach to preventing the burst effect and 
achieving a more ideal drug release profile is to improve the drug distribution within 
the polymeric matrix. Therefore, it is of great importance to establish a rapid and 
robust tool for screening and optimizing the drug distribution during pre-formulation. 
Transition Temperature Microscopy (TTM), a novel nano-thermal and imaging 
technique, is an extension of nano-thermal analysis (nano-TA) whereby a transition 
temperature is detected at a localized region of a sample and then designated a color 
based on a particular temperature/color palette, finally resulting in a coded map based 
on transition temperatures detected by carrying out a series of nanoTA measurements 
across the surface of the sample. In this study, we investigate the feasibility of 
applying the aforementioned technique combined with other thermal, imaging and 
structural techniques for monitoring the drug microstructure and spatial distribution 
within bovine serum albumin (BSA) loaded and nimodipine loaded PLGA 
microspheres, with a view to better predicting the in vitro drug release performance. 
Keywords 
Transition temperature microscopy; Microsphere; Bovine serum albumin; 
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1. Introduction  
In recent years microspheres fabricated with biodegradable materials, such as 
poly (d,l-lactic-co-glycolic) acid (PLGA), have attracted significant attention [1-3]. 
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Microspheres have been developed to encapsulate different classes of drugs including 
biopharmaceuticals [4,5], small molecules [6,7] and natural products [8,9]. The main 
driving force for developing such microspheres has typically been to prolong the 
duration of action of the incorporated drugs. In addition, microsphere formulations 
have also been shown to possess other advantages, including site-specific release with 
a concomitant reduction in toxicity [10, 11]. However, there are still limitations 
regarding drug release from polymeric microspheres that remain unresolved; these 
include burst release effects, low drug release rates (and hence concentrations) at later 
stages and incomplete release due to drug entrapment within the microspheres. 
Among these, the burst release effect is the most problematic issue, particularly for 
water-soluble drugs [12]. In order to understand the mechanisms underpinning burst 
release, and to minimize such effects, the drug distribution and microstructure within 
the polymeric matrix should be more fully understood.  
The investigation of drug uptake and distribution within microspheres has focused 
largely on the measurement of the drug loading using a range of assay methods. The 
content of small molecule drugs encapsulated in microspheres is usually measured by 
titration, high performance liquid chromatography (HPLC) or UV spectrophotometry, 
while the Kjeldahl, Folin-phenol or bicinchoninic acid (BCA) methods [13] are used 
to determine the loading of peptide or protein therapeutics. Other analytical 
techniques that are routinely used to characterize microsphere formulations include 
modulated temperature differential scanning calorimetry (MTDSC) to study the 
amorphous properties of the microspheres, X-ray diffraction (XRD) [14] to study the 
crystallinity and Fourier transform infrared spectroscopy (FTIR) [15] to study the 
chemical composition and interactions within the systems.           
The characterization methods routinely used to analyze microspheres have some 
common limitations in that they interrogate the bulk sample rather than individual 
microspheres, while such methods also do not provide information regarding the 
spatial distribution of the drug within the system. In addition, traditional drug loading/
encapsulation measurements are normally lengthy and complex, hence it is of 
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considerable interest to establish a rapid and robust analytical platform for fast 
evaluating the drug content and spatial distribution within the microspheres. 
Transition temperature microscopy (TTM) is a novel technique for automated 
analysis of the local temperature transitions over an area of a sample surface. 
Typically, thermal analysis methods such as differential scanning calorimetry (DSC) 
are used to measure thermal transitions such as the melting point (Tm) of crystalline 
materials and the glass transition temperature (Tg) of amorphous samples. This 
technique, however, is usually performed on bulk samples and therefore the 
transitions measured are not spatially differentiated. For this reason, further research 
and development was conducted on local measurements of thermal phase transitions 
using heated probe tips based on Atomic Force Microscopy (AFM) [16-18]. As a 
result, Micro Thermal Analysis (μTA) and Nano Thermal Analysis (Nano TA) have 
been successively developed. Nevertheless, both the conventional μTA and NanoTA 
measurements are carried out manually at single points or a handful of points without 
the ability to automatically resolve special variations in thermal transition 
temperatures. TTM is a recent extension of NanoTA whereby transition temperatures 
are detected at a series of points in a defined region of a sample; these points are then 
color-coded based on the transition temperature, resulting in a map based on transition 
temperatures detected across the surface of the sample [19-20]. This method therefore 
has the potential to determine the distribution of the drug and polymer across the 
surface and cross section of a single microsphere.   
In this study, nimodipine, a hydrophobic drug with a molecular weight of 418, and 
bovine serum albumin (BSA), a hydrophilic protein with a molecular weight of 
approximately 68 KDa, were selected as small and large molecular weight drug 
models. Nimodipine-PLGA microspheres and BSA-PLGA microspheres were 
prepared with three levels of drug loading.  The morphology and in vitro release of the 
different microsphere formulations were then studied. Additionally, TTM was used to 
study the drug distribution on the surfaces and on the internal cross-sections of single 
microspheres. Finally, modulated temperature differential scanning calorimetry 
(MTDSC), X-ray diffraction (XRD) and Fourier transform infrared spectroscopy 
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(FTIR) were also used to analyse the bulk properties of the systems. By combining 
the above methods, the drug distribution and microstructure within the different types 
of microspheres could be interpreted more comprehensively. The study therefore 
explores the utility of TTM as a novel tool to provide a more detailed understanding 
of spatial distribution of drugs in microspheres, with a view to providing insights into 
the relationship between such distribution and in vitro release.  
2. Materials and Methods 
2.1 Materials  
Bovine serum albumin (BSA) was purchased from American Genview Co. 
(USA). Nimodipine was purchased from Zhuhai Yuan-Cheng Med-chemical Co. Ltd. 
(Zhuhai, China). The PLGA (Lactide:Glycolide 50:50) was obtained from Absorbable 
Polymers International (Birmingham, USA). Polyvinyl alcohol-124 (PVA) and 
Poloxamer (F68) were obtained from Shantou Chemical Regents Co. (Shantou, 
China). Tween 80 was purchased from BASF (Ludwigshafen, Germany). 
Dichloromethane and sodium chloride were obtained from Guangzhou Chemical 
Regents Co. (Guangzhou, China).  
2.2 Preparation of Microspheres  
Preparation of nimodipine-PLGA microspheres (nimodipine-PLGA) using a 
membrane emulsification method 
PLGA (15%, w/v) and nimodipine with three different loadings (see Table 1) 
were firstly dissolved in 5mL dichloromethane to form the dispersed phase, which 
was then added to the Shirasu Porous Glass (SPG) membrane emulsification machine 
and extruded through the SPG membrane under N2 pressure to achieve uniform-sized 
droplets; 200ml PVA solution (1%, w/v) was used as the continuous phase. The mix 
was further stirred at 250 rpm for 4hr at room temperature after which the majority of 
dispersed phase was dispersed into the continuous phase and emulsion drops 
solidified following dichloromethane evaporation. Microspheres were then washed 
with de-ionized water and finally collected after filtration and a 24hr drying. 
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Preparation of BSA-PLGA microspheres (BSA-PLGA-MS) using a double 
emulsion-solvent evaporation method 
PLGA (15%, w/v) was dissolved in dichloromethane to form the organic phase. 
BSA with three different loadings (see Table 1) was dissolved in a F68 solution (1%, 
w/v) to form the internal aqueous phase, which was then added to organic phase while 
stirring at a suitable temperature and speed to form the initial W/O emulsion. The W/
O emulsion was then added to PVA solution (external aqueous phase) while stirring 
for 10 min to form the double emulsion and then transferred to a PVA solution while 
stirring slowly to solidify the microspheres by extraction, which were then washed 
prior to freeze drying. 
2.3 Determination of Drug Loading and Encapsulation Efficiency  
Nimodipine-loaded microspheres (20 mg) were dissolved completely in 1 mL 
dichloromethane and then diluted 100-fold with ethanol in a 10 mL volumetric flask, 
followed by centrifugation under 10,000 rpm for 20 minutes. Finally the nimodipine 
concentration in the supernatant was determined spectrophotometrically (356nm). 
BSA-loaded microspheres (10 mg) were suspended in 5 mL SDS solution (5% 
w/v) with 0.1 M NaOH. The suspension was then shaken in the water bath at 37℃ for 
48h to ensure the microspheres were completely dissolved. The supernatant was 
extracted after centrifugation, and the protein content was determined using the 
Bicinchoninic Acid (BCA) method.  
2.4 Measurement of Particle Size and Size Distribution  
Particle size and size distribution of the microspheres were measured using a 
laser diffraction particle size analyzer (Counter LS130, USA) using water as the 
dispersion medium. 
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2.5 Scanning Electron Microscopy (SEM) 
The morphology of both the microsphere surfaces and the cross-sections were 
imaged by scanning electron microscopy (SEM) (Hitachi S-4800, Japan) after being 
coated with gold in an argon atmosphere. To section the particles, the microspheres 
were firstly suspended in two different embedding agents: optimal cutting temperature 
(OCT) compound (Shanghai solarbio Bioscience & Technology Co., LTD, China), 
and an aqua solution containing gelatin and glycerin prior to solidification via being 
stored at -20℃. The fixed samples were then frozen in liquid nitrogen for 5min and 
cryosectioned under -40℃based on an established method [21].    
2.6 In vitro Drug Release Measurement 
Prior to the in vitro release test, 5 mL solution of nimodipine in phosphate 
buffered saline (PBS, pH7.4) solution (containing 0.5% w/v SDS) was placed in a 
dialysis bag which was submerged in 195 ml PBS solution in a constant temperature 
oscillator held at 37 ℃± 0.2 ℃  with 100 rpm rotation speed. The concentration of 
nimodipine inside or external to the dialysis bags was found to be the same after 2hr, 
indicating the dialysis bag itself did not affect the drug transport. 
Nimodipine-loaded microspheres (30 mg) were placed in a dialysis bag, and 5 
mL phosphate buffered saline (PBS, pH7.4) solution (containing 0.5% w/v SDS) 
added to disperse the microspheres. The dialysis bag was then submerged in PBS 
solution (195 mL), and the in vitro release test was conducted in a constant 
temperature oscillator at 37 ℃± 0.2 ℃  and 100 rpm rotational speed. At pre-
determined time points, 5mL of the release medium was sampled and fresh medium 
added to maintain a constant total volume. The amount of drug released at each time 
point was quantified by UV spectrophotometry using a standard curve.  
BSA-loaded spheres (50 mg) were placed in a centrifuge tube and PBS solution 
(1.5 mL) was added. The centrifuge tube was then put in a water bath oscillator to 
conduct the in vitro release test at 37 ℃± 0.2 ℃  and 100 rpm rotational speed. At 
each time point, the sample was centrifuged, and the supernatant was sampled to 
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determine the protein content using the BCA method. Fresh release medium was 
added in the centrifuge tube to continue the release experiment. 
2.7 X-ray Diffraction (XRD) 
XRD (Bruker D8 Advance, Germany) measurements were carried out at a 
voltage of 40 kV and a current of 40mA. Data was collected at a scan rate of 0.02°/
0.15over a range of 5 to 50° 2θ. 
2.8 Fourier Transform Infrared (FTIR) Spectroscopy  
The raw materials of nimodipine and BSA, and blank and drug-loaded 
microspheres were mixed with potassium bromide (KBr) respectively, ground and 
tableted. The scan range was from 4000 to 400 cm-1.
2.9 Modulated Temperature Differential Scanning Calorimetry (MTDSC) 
MTDSC (Q1000 TA Instruments, Delaware, USA) measurements were carried 
out at 2 °C/min with a modulation of ±0.212°C for every 40s over a temperature 
range of 0 to 250 °C using standard pans. The instrument was calibrated with indium, tin 
and octadecane before use. 
2.10 Transition Temperature Microscopy (TTM) 
TTM was performed on both raw materials and microspheres using a VESTA 
TM system equipped with an AN-200 ThermaLever probe, both from Anasys 
Instruments (Santa Barbara, USA). With raw materials in loose powder, a mini tablet 
sample was made to ensure a flat and smooth surface for TTM measurement. To 
investigate the cross section of the microspheres, samples were sectioned using the 
same method as stated in 2.5. The voltage was calibrated to temperature by carrying 
out LTA measurements on three standard polymeric samples with known melting 
points. The experiments were carried out from room temperature at a heating rate of 
10 °C/s. For each sample, an area of 50 x 50 µm was analysed.  
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3. Results  
3.1 Measurement of particle size, drug loading and encapsulation efficiency  
The drug loading and encapsulation efficiencies of the different microsphere 
formulations were measured and are listed in Table 1. With both model drugs, the 
lowest drug loading resulted in a relatively high encapsulation efficiency while the 
particle size increased with an increase in drug loading. It is noted that the particle 
size with a general distribution of 65-100 µm did not vary significantly among 
different formulations, making the later analysis of drug release profiles less 
complicated. 
Table 1. Particle size, drug loading and encapsulation efficiency measured for 
BSA and nimodipine microspheres. 
Formulation
Drug loading 
(%)
Encapsulation 
efficiency (%)
Mean particle size 
(µm)
BSA microspheres 1 
(MS1)
3.66±1.05 88.70±1.21 64.16±1.16
BSA microspheres 2 
(MS2)
6.47±1.35 78.45±1.47 77.30±1.77
BSA microspheres 3 
(MS3)
8.84±1.26 79.57±1.36 100.85±2.53
Nimodipine 
microspheres 4 
(MS4)
8.30±1.02 96.50±1.25 67.87±3.13
Nimodipine 
microspheres 5 
(MS5)
14.10±1.31 84.90±1.44 84.17±2.46
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 3.2 SEM results 
SEM showed that the surfaces of BSA-loaded microspheres (Figure 1 a-c) were 
relatively smooth compared to that of nimodipine systems (Figure 1d-f), with the 
latter showing some evidence for the presence of surface crystallites at higher 
loadings.  For the cross-sections, BSA-loaded microspheres showed a considerable 
amount of internal cavities while the nimodipine-PLGA microspheres showed a much 
smoother internal morphology, with only the highest drug loading appeared to present 
cavities. The difference between the two model drug systems in both the surface and 
cross section morphology was partially due to the different methods of preparation 
applied and partially due to the different properties of the two model drugs. 
Nimodipine is a lipophilic drug and is expected to have good miscibility with PLGA, 
hence it is quite likely for such a drug to be molecularly dispersed in the PLGA 
matrix. The fact that both components were dissolved in a single disperse phase 
during the preparation may explain why the cross-sections of nimodipine 
microspheres did not exhibit as many cavities as BSA microspheres did. Likewise the 
crystals on the surface may be caused by recrystallization of a small amount of 
nimodipine during the evaporation of the organic solvent, leading to crystallite 
adhesion to the surface of the microspheres.     
When preparing the BSA microspheres with the double emulsion solvent 
evaporation method, the hydrophilic protein and PLGA, a lipophilic polymer, were 
dissolved in distinct aqueous and organic solvents, respectively. During the 
solidification process, BSA could not be mixed with PLGA and remained dispersed in 
the solid PLGA particles within aqueous droplets due to the significant solubility 
difference between the two components and the lack of miscibility between the two 
Nimodipine 
microspheres 6 
(MS6)
22.80±1.28 87.40±1.50 93.29±2.13
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solvent systems used. Finally, after the microspheres were freeze-dried, the aqueous 
solvent was removed and the cavities seen in the cross sections were formed.   
! !  
a.   Microsphere 1: 3.66% BSA loaded PLGA microspheres 
! !
b.   Microsphere 2: 6.47% BSA loaded PLGA microspheres 
! !
c.   Microsphere 3: 8.84% BSA loaded PLGA microspheres 
! !
d.  Microsphere 4: 8.30% nimodipine loaded PLGA microspheres 
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e.   Microsphere 5: 14.10% nimodipine loaded PLGA microspheres 
! !
f.   Microsphere 6: 22.80% nimodipine loaded PLGA microspheres 
Figure 1:   SEM images of the outer surface (left) and cross section (right) of BSA 
loaded PLGA microspheres (a-c) and nimodipine loaded PLGA microspheres (d-
f) with various drug loadings.
3.3 In vitro drug release profiles 
As shown in Figure 2, the burst release from BSA microspheres was significant 
with a large proportion of BSA being released during the first hour. After 40 days, 
there was still a considerable amount of drug that remained unreleased from the 
formulation. This burst release phenomenon was probably caused by the hydrophilic 
nature of BSA; the aqueous solubility of BSA is high, therefore when the BSA 
microspheres were placed in an aqueous medium for the in vitro release studies, the 
BSA molecules present near the surface would quickly dissolve and diffuse into the 
bulk release medium, which at least partially accounts for the observed burst release. 
There are a number of factors that may affect the burst release, including the drug 
solubility, the overall drug loading and the drug level on the surface of the 
microspheres.  
In terms of the nimodipine microspheres, the drug was released at a relatively 
constant rate throughout the first 40 days of the in vitro release study, indicating a 
well sustained release profile.  After 40 days, the drug was not completely released, 
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although up to this point the release rate remained largely constant. The in vitro 
release of nimodipine from microspheres appeared to be controlled by the degradation 
of PLGA based on previous studies/recognition of PLGA as a biodegradable polymer 
for sustained release.  
!
!
Figure 2   In vitro drug release profiles of BSA loaded PLGA microspheres, with 
the early stages of drug release profiles being enlarged in the lower figure 
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Figure 3   In vitro drug release profiles of nimodipine loaded PLGA microspheres  
3.4 XRD results 
The XRD results are shown in Figures 4 and 5. The diffractogram of BSA alone 
displayed a broad halo which indicated that the raw material existed in the amorphous 
form (Figure 4). The diffractogram corresponding to microsphere3, which had the 
highest BSA load of 8.8%, still exhibited no intense Bragg reflections; therefore, the 
amorphous form persisted on entrapment in the microspheres. 
 Nimodipine exhibited numeroussharp and intense Bragg reflections in the 
diffractogram, indicating that the raw material of nimodipine existed in the crystalline 
form (Figure 5). In terms of the nimodipine microsphere formulations, microspheres4 
and microspheres 6 (drug loadings of 8.30% and 22.80%, respectively) both exhibited 
the characteristic Bragg reflections of the nimodipine crystals. However, the 
characteristic nimodipine crystalline peaks in these formulations were all very weak. 
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Figure 4 XRD traces of BSA loaded PLGA microspheres with the greatest drug 
loading (microsphere 3) and reference samples 
 
Figure 5   XRD traces of nimodipine loaded PLGA microspheres with the lowest 
(microsphere 4) and highest drug (microsphere 6) loadings and reference 
samples 
3.5 FTIR results 
Figure 6 shows the FTIR spectra of the BSA raw material, blank microspheres 
and BSA microspheres with different drug loading. The FTIR spectrum for the BSA 
raw material showed a characteristic peak of BSA at 1656cm-1, representing the 
BSA 
Blank 
8.84%BSA-MS
NMP 
Blank 
8.30%NMP-MS 
22.80%NMP-MS
!16
stretching vibration peak of –C=O in the amide Ι band of BSA. It was found that an 
increase in BSA loading in the microspheres resulted in an increase in the intensity of 
the amide I band, which suggested enhanced BSA encapsulation in the microspheres 
as expected. 
However, it was noteworthy that in the FTIR spectra of BSA microspheres the 
characteristic amide Ⅰ band was red shifted to 1635, 1635, 1639 cm-1 for microspheres 
1, 2 and 3, respectively. The characteristic peaks corresponding to the amide I  band 
are very sensitive to changes of the secondary structures of protein. The peaks at 
1650-1658 cm-1 represented the α-helix structure while the peaks at 1620-1640 cm-1 
represented the β-sheet structure.  The FTIR spectra of the BSA-loaded microspheres 
suggested that the majority of α-helix structure in BSA had changed to β-sheet 
structure after being encapsulated into microspheres. This may be due to the forming 
of hydrogen bonds between BSA and PLGA during encapsulation.  
Figure 7 showed the FTIR spectra of the nimodipine raw material, blank 
microspheres and nimodipine microspheres with different drug loading. The FTIR 
spectrum of nimodipine raw material displayed two characteristic peaks of 
nimodipine at 3300cm-1 and 1694 cm-1, which represented the stretching vibrations of 
N-H and –C=O of nimodipine, respectively. Similar to the BSA microspheres 
discussed earlier, the intensity of the peaks reflected the extent of encapsulation of 
drug in the microspheres. In terms of the peak positions for the nimodipine loaded 
microspheres, the position of the N-H stretching vibration blue shifted from 3300cm-1 
with the pure drug to 3390, 3397, 3387 cm-1 with microspheres 4, 5 and 6 
respectively, and the position of the –C=O stretching vibration shifted slightly from 
1694 cm-1 to 1697 cm-1 with all formulations. 
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Figure 6   FTIR spectra of BSA loaded PLGA microspheres and reference 
samples 
&  
Figure 7   FTIR spectra of nimodipine loaded PLGA microspheres and reference 
samples 
3.6 MTDSC results 
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    The results of MTDSC were shown in Figures 8-10. The thermal properties of the 
raw materials of BSA, nimodipine and PLGA were determined first. As shown in 
Figure 8(a), BSA was characterized by two endothermic peaks at 62.5 ℃  and 215.9 
℃. Previous studies [22, 23] have shown that BSA experiences two phases of change 
during the heating process. In the first stage, occurring at a lower temperature, the α-
helix peptides may change conformation and assemble to form a random coil 
structure; in addition, the adjacent inverted parallel α-helix peptides may form a β-
sheet structure through hydrogen bonds during the heating process. The changes at 
this stage are reversible. This stage involves a plurality of structural changes between 
many different protein structures hence the endothermic peak looks broad. In the 
second stage at a higher temperature, BSA degraded and the structural changes are 
irreversible. Based on the previous findings above, we may reasonably ascribe the 
first endothermic peak of BSA measured at 62.5℃ to a result of reversible changes 
and the second endothermic peak at 215.9 ℃ to an irreversible degradation.  
    As demonstrated in Figure 8(b), the thermodynamic properties of raw nimodipine 
materials were easier to analyze than those of BSA, due to its smaller molecular size 
and simpler chemical structure. Only one narrow endothermic peak at 125.8 ℃, 
representing the melting point of the crystalline material, was present in the 
thermogram. In terms of PLGA raw material (Figure 8(c)), it was characterized with a 
single Tg at about 48.1℃, which was accompanied with an endothermic relaxation 
measured at 45.9℃ in the total heat flow of the MTDSC data, indicating the pure 
amorphous nature of PLGA.  
    The MTDSC results of the BSA-PLGA microspheres with different drug loadings 
are shown in Figure 9. The thermograms showed that with increasing drug loading the 
endothermic peaks associated with BSA changed accordingly. Since both BSA and 
PLGA had an endothermic transition around 50 ℃, and the drug loadings in the BSA 
microspheres were relatively low, the peaks associated with BSA at about 50 ℃ were 
overshadowed by the peaks associated with PLGA, hence  the thermograms mainly 
showed the features of the PLGA. However, since the endothermic peaks near 50 ℃ 
were the superposition of the two components, when the amount of PLGA was almost 
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unchanged, the area of the peak became larger with the increase of BSA loading. The 
endothermic peak measured with BSA alone at 215.9℃ was not present in the 
thermograms of the BSA-PLGA microspheres, which was likely to be due to a 
combination of the low drug loading and the weak nature of such a thermal transition. 
Further increase in BSA loading, however, did appear to result in a more visible 
endothermic peak.  
    The MTDSC results of the nimodipine-PLGA microspheres with different drug 
loadings were shown in Figure 10.  As stated earlier, pure nimodipine presented a 
melting point at 125.8 ℃. As for PLGA based microspheres, a ‘depressed melting’ 
was detected, indicating the compatibility/interaction (hydrogen bonding) between the 
two components. It was found that the higher the drug loading the greater the 
depressed temperature. The enthalpy of this transition also increased with drug 
loading; implying the nimodipine loading of microspheres had a positive correlation 
with the endothermic peak area. In addition, an endothermic relaxation peak was 
detected for all nimodipine loaded microspheres between 44-48℃, indicating a glass 
transition of the amorphous phase. It was notable that no marked plasticizing effect 
was seen which may be due to similar glass transition temperatures between PLGA 
and nimodipine.
&  
a
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Figure 8 MTDSC heat flows of BSA (a), nimodipine (b) and PLGA (c) raw 
materials 
c
b
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Figure 9 MTDSC heat flows of BSA loaded PLGA microspheres with three levels 
of drug loading 
!  
Figure 10 MTDSC heat flows of nimodipine loaded PLGA microspheres with 
three levels of drug loading 
3.7 TTM results 
Transition temperature microscopy (TTM) is a relatively new technique which 
involves mapping a sample surface via the temperature at which a heated probe 
indents into that surface, thereby effectively creating a map of softening points.   The 
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TTM color coded maps shown here correspond to an area of 50 x 50 µm for each 
sample. The corresponding histogram is a summary of the measured penetration 
temperatures. The temperature peak with the greatest intensity in the histogram 
corresponds to the most prevalent component/phase in the sample. 
TTM was firstly used to analyze the raw materials of BSA, nimodipine and 
PLGA. The results were shown in Figure 11. In the transition map of BSA, it was 
shown that BSA had several different thermal transitions which were expressed as 
different characteristic color blocks. It had previously been shown that BSA consisted 
of peptides of different secondary structures: 50-68 % of which are α-helix peptides, 
and 16-21 % β-sheet [24, 25]. Characteristic peaks appeared at multiple temperature 
points in the histogram of BSA, and the strongest response was concentrated in the 
region above 100 ℃, which could be used to analyze BSA qualitatively in the later 
experiment.       
        The thermal transition map of nimodipine consists largely of a single 
characteristic color. Nimodipine is a crystalline small molecule drug that has high 
purity when chemically synthesized and therefore it has a defined melting point. 
These material characteristics account for the single color observed in the thermal 
transition map as well as the comparatively narrow distribution of thermal transitions 
in the histogram for this material. Specifically, the transitions occurred in the range of 
60-90 ℃, with the highest frequency occurring at approximately 80 ℃.  
        The thermal transition map of the PLGA raw material was also fairly consistent. 
The histogram shows that the characteristic thermal transition peaks of PLGA occur at 
50-55 ℃. These findings agreed well with the value measured using DSC, i.e. 
48.1℃. 
After the qualitative analysis of the three substances individually, drug 
distribution on the surface and cross-sections of both BSA-PLGA and nimodipine-
PLGA microspheres with different drug loadings were analyzed with TTM. Figure 12 
showed that due to the great difference of the transition temperatures between BSA 
and PLGA, the distribution of BSA on the surface and internal cross-section of the 
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BSA-PLGA microspheres could be clearly seen. In the transition maps of the BSA-
PLGA microspheres, the transitions occurring at a lower temperature, represented by 
blue blocks, were the areas of PLGA; while the transitions occurring at a higher 
temperature, represented by bright green blocks, were the areas of BSA. The 
transition maps of both the surfaces and the cross-sections of the microsphere 
formulations showed that when the BSA loading is increased from 3.66 % to 8.84 %, 
there was a clear increase in the characteristic colors of BSA on the transition maps. 
Additionally, the quantity and intensity of the peaks on the histograms in the region 
above 100 ℃  (which can be attributed to BSA thermal transitions) increased with 
increasing BSA load. However, it must be noted that the actual drug loadings (3.66% 
and 8.84%) measured using chemical method were determined on the bulk samples 
while TTM was mapping the drug distribution on the localized surface regions of a 
single microsphere. Therefore, the size of the total areas of a specific color in the 
TTM map would not necessarily reflect on the overall drug loading. 
Comparing the TTM results of the surfaces and cross-sections of the 
microspheres with equal drug loading, it was found that there was more area covered 
by the color blocks associated with BSA inside the microsphere than on the surface. 
As would be expected, the quantity and intensity of the peaks associated with BSA in 
the histograms produced of the transition temperatures of the microsphere cross-
section were all higher than those in the histograms of microsphere surface. This TTM 
data suggested that for BSA-PLGA microspheres of equal drug loading, more BSA 
was distributed on the interior of the microspheres than on the surface. 
The TTM results of nimodipine microspheres are shown in Figure 13. The results 
of the raw material characterization showed that the transition temperatures of PLGA 
and nimodipine determined by TTM were very close, which means that the 
characteristic color blocks of the two components were very similar. Therefore, with 
the nimodipine-PLGA microspheres, the transition temperature maps largely 
consisted of a single color block and it was very difficult to distinguish the areas 
corresponding to nimodipine and PLGA and also hard to monitor the distribution of 
nimodipine on the surface and cross-section of PLGA microspheres. It is suggested 
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that TTM technique is not able to monitor microstructure/drug distribution with all 
microsphere formulations. A critical criterion/limitation for applying this technique is 
that there must be a marked difference between the thermal transition temperatures of 
each individual components/phases in the formulation. For instance, the thermal 
transitions of nimodipine rich region and PLGA rich region were at similar 
temperatures hence overlapping characteristic color blocks in the TTM map, which 
complicated the differentiation. In terms of the magnitude of such difference, it is 
indicated in this study that it should be at least over circa 40℃ to generate distinct 
colors in TTM map. It was also interesting to find some round dark pink color areas in 
a majority of TTM maps, which could most probably be a cavity/gap region. When 
the probe (30nm in diameter) landed at a cavity point, there was no contact between 
the probe and the material and this is normally processed by the software as a low 
(0℃) temperature reading. This has also been seen in other investigations by our 
group. 
Due to the limitation of using TTM color coded map discussed above, the 
histograms produced from the transition temperatures can be used to obtain more 
information about the loading of the different components. The temperature peak with 
the greatest intensity in the histogram corresponds to the most prevalent component/
phase in the sample. In terms of the nimodipine-PLGA microspheres in this study, at 
the transition temperatures near 80 ℃, where the transitions associated with 
nimodipine appeared, the quantity and intensity of the histogram peaks increased with 
increasing nimodipine load. Furthermore, when comparing the histograms of the 
surfaces and cross-sections of nimodipine microspheres, both the quantity and 
intensity of the characteristic peaks of nimodipine in the histograms of the 
microsphere cross-sections were higher than those in the histograms of the 
microsphere surface. These results indicated that when nimodipine-PLGA 
microspheres were prepared by the membrane-emulsification method, more 
nimodipine was present in the interior of the microsphere than on the surface. This 
relationship was more obvious in the TTM results of the nimodipine microspheres 
with the higher drug loading of 22.80%. At the lower nimodipine loading of 8.30% 
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the histogram peaks associated with the transition temperature of nimodipine were 
fewer, making this relationship indistinctive. 
In terms of the two thermal analysis approaches used in this study, i.e. MTDSC 
and TTM, MTDSC measures all the thermal transitions of the bulk sample while 
TTM only picks up the first significant response to the increased temperature at each 
data point within a small local region of the sample, including thermal transitions (e.g. 
melting, glass transition) as well as any other responses which involves probe sinking 
in, such as simply sample softening. In this case, there is always a difference in 
temperature measured between MTDSC and TTM. The pattern of variation normally 
depends on the nature of the sample under investigation, rather than following a 
definitive trend. This explains the different variations observed with BSA and 
nimodipine samples. Comparatively, there was a greater variation associated with 
BSA as compared to nimodipine. This was mainly due to the larger and more complex 
structure of BSA. However, we should note that the first thermal transition of BSA 
measured using MTDSC (Fig. 8(a)) showed a very ‘broad’ peak with a maximum 
value at 62.5℃ and an offset between 100-150℃, which better agreed with the TTM 
observation, i.e. over 100℃. 
! !  
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   
Figure 11 TTM color coded map (left) and corresponding histogram (right) of 
BSA, nimodipine and PLGA raw materials (top to bottom)
   
a. The outer surface of 3.66% BSA loaded PLGA microspheres 
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   
b. The outer surface of 8.84% BSA loaded PLGA microspheres 
   
c. The cross section of 3.66% BSA loaded PLGA microspheres 
   
d. The cross section of 8.84% BSA loaded PLGA microspheres 
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Figure 12 TTM color coded maps (left) and corresponding histograms (right) of 
the outer surface (a-b) and cross section (c-d) of BSA loaded PLGA microspheres 
with the lowest and highest drug loading 
! !  
a. The outer surface  of 8.30% nimodipine loaded PLGA 
microspheres 
! !  
b. The outer surface of 22.80% nimodipine loaded PLGA 
microspheres 
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c. The cross section of 8.30% nimodipine loaded PLGA microspheres 
! !  
d. The cross section of 22.80% nimodipine loaded PLGA 
microspheres 
Figure 13 TTM color coded maps (left) and corresponding histograms (right) of 
the outer surface (a-b) and cross section (c-d) of nimodipine loaded PLGA 
microspheres with the lowest and highest drug loadings.
4. Discussion  
In this study several PLGA microsphere formulations produced with two 
different model drugs and preparation methods were extensively characterized with 
SEM, XRD, FTIR, MTDSC and TTM. SEM was able to show differences in surface 
and internal morphology of the microsphere formulations produced by two different 
preparation methods. XRD was employed to analyze the physical state of the drugs 
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encapsulated in the microspheres, while FTIR allowed analysis of the molecular 
structure of the drugs in microspheres. MTDSC was able to analyze the bulk 
thermodynamic properties of the microsphere products. TTM, meanwhile, is a 
spatially resolved thermal analysis technique that was applied in the study to analyze 
the surface and cross-sections of individual microspheres.  
Since the encapsulated drug and PLGA polymer had their own thermal 
properties, the corresponding color blocks of the different components shown in maps 
were also different. As a result, the loading and distribution of a certain substance in a 
selected area could be easily determined by observing the thermal transition maps, if 
the thermodynamic properties of the materials were significantly different. The role of 
the histograms in TTM was similar to MTDSC.  
The results of TTM, however, were strongly influenced by the properties of the 
sample itself: 
(1) The thermal transitions of nimodipine and PLGA occurred at a similar 
temperature which resulted in the characterstic color blocks also being very similar; 
therefore, when analyzing nimodipine-PLGA microspheres, it was not possible to 
determine the loading or distribution of the components from the TTM maps. When 
melting point difference of two substances is over 40℃ TTM technology can be used 
to determine drug distribution.
The thermodynamic properties of BSA and PLGA were very different, however, 
and as a result it was possible to visually distinguish regions of BSA and PLGA on the 
TTM maps produced, allowing spatial distribution and BSA loading to be 
qualitatively assessed. It was noteworthy that, BSA showed a variety of color blocks 
in its own map probably because of containing the peptides with different secondary 
structures. However, in the thermal transition maps of the BSA microspheres, BSA 
was just shown by bright green color blocks, while the color blocks representing the 
higher temperature transitions (such as the yellow and red blocks) were not present. 
This phenomenon was reflected in the histograms of BSA microspheres. In the 
histogram of BSA raw material, the region where the quantity and intensity of the 
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thermal transition peaks was highest was concentrated in the 150-200 ℃ region. The 
quantity and intensity of the thermal transition peaks appearing at the 100-150 ℃ 
region were lower than those in 150-200 ℃  region. However, when analyzing the 
histograms of the BSA microspheres, the thermal transition peaks of BSA mainly 
appeared in the lower range of 100-150 ℃.  
The TTM results suggest that after being encapsulated into microspheres, the 
thermal transitions of BSA tended to occur at a lower temperature. The FTIR results 
showed that after being encapsulated most of the α-helix peptides in BSA changed 
conformation to β-sheet peptides. This change in secondary structure was probably 
caused by the formation of hydrogen bonds with PLGA in the polymer matrix. 
Moreover, with the formation of hydrogen bonds, the two components transformed to 
a relatively stable “dispersed system”, the thermal properties of which fell in between 
those of BSA and PLGA separately. More specifically, the transition temperatures of 
BSA-PLGA individual microspheres as determined by TTM presented a lower 
temperature as compared to BSA alone due to the contribution of the thermal 
properties of PLGA. Furthermore, it was also found that BSA within the PLGA matrix 
showed a significantly slower release rate although it has a high solubility. This was 
due to the hydrophilic nature of the drug as well as the hydrogen bonding formed 
between the drug and matrix in the dispersed system.  
One can conclude from the findings above that TTM is a very promising 
technique for monitoring the microstructure of individual microspheres provided that 
all components in the formulation present a considerable difference in their thermal 
properties.  
(2) The drug loading achieved in the nimodipine-PLGA microspheres was 
significantly higher than that achieved in the BSA-PLGA microspheres; however, in 
the histograms the thermal transition peaks associated with nimodipine were much 
lower than the peaks associated with BSA. Also, in the TTM maps of BSA 
microspheres, the area that was associated with BSA transitions was very large even 
though the drug loading was low. The differences in the structure and properties 
!32
between nimodipine and BSA as well as their compatibility with PLGA as detailed 
below may explain this phenomenon.  
Nimodipine is a small molecule drug, with a molecular weight of 418 and a 
simple spatial structure while PLGA is a long chain polymer. Due to the lipophilic 
nature of both materials, they present very good compatibility. The SEM images 
showed very few cavities in the cross-section of the nimodipine-PLGA microspheres, 
demonstrating a rather solid structure with such a formulation. The relatively high 
compatibility between nimodipine and PLGA as well as the stabilizing effect of 
PLGA on the relatively small molecules resulted in a well dispersed system, as 
reflected by XRD and MTDSC. 
The molecular weight of the BSA (approximately 68 KDa) is much larger than 
nimodipine, and as a protein molecule, BSA has a spatial configuration with very 
complex secondary and tertiary conformations. These properties indicate that the 
same mass of BSA would occupy much larger space as compared to nimodipine. Its 
hydrophilic nature also makes it less compatible with PLGA. As a consequence, the 
SEM images showed many cavities inside the BSA microspheres due to the 
microspheres being prepared by double emulsion-solvent evaporation technique. The 
combination of MTDSC and XRD results demonstrated a fully amorphous structure 
with two separated phases for BSA-PLGA microspheres. This was most likely due to 
the incompatibility between BSA which is hydrophilic and water-soluble, and PLGA 
which is lipophilic and soluble in organic solvent. Therefore, once BSA was 
encapsulated within the microspheres it could only stay in the cavities of the PLGA 
matrix formed as a result of the double-emulsion production method, retaining its 
original independent phase. As a result, although the drug loading of BSA 
microspheres was low, the BSA distribution area shown in the TTM maps was 
relatively large as the system was phase-separated. To conclude, the differences in the 
chemical nature and solubilities of the components, and therefore the preparation 
method required for a formulation, would significantly affect the microstructure 
measured by TTM.  
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 (3) Comprehensive analysis of the results of TTM and the other analytical 
techniques increased the understanding of the spatial drug distribution within two 
different types of microspheres, and also contributed to the increased understanding of 
the in vitro drug release behaviors from the microspheres. The TTM results of the 
BSA-PLGA microsphere surface showed a reasonable quantity of BSA was present at 
the surface of the formulation. BSA molecules present near the microsphere surface 
would quickly dissolve and diffuse into the bulk aqueous release medium resulting in 
the burst release effect observed. However, the TTM maps also showed that the BSA 
present on the surface of the microspheres was just a small part of the total drug 
content as the TTM maps of the microsphere cross-sections showed that more BSA 
appeared to be present inside the microspheres. Therefore, despite the significant 
burst release, the majority of the BSA was distributed inside the microspheres and was 
not so easily released. The TTM results and in vitro release studies supported each 
other well for the BSA-PLGA microsphere formulations.  
 Due to the good chemical compatibility between nimodipine and PLGA, 
nimodipine could be distributed uniformly in the amorphous state throughout the 
PLGA matrix in the nimodipine-PLGA microspheres. The TTM results supported this 
proposed distribution, and the in vitro release studies show that nimodipine was 
released with a relatively constant rate as the PLGA matrix degraded. Therefore, the 
TTM results and in vitro release studies were again in agreement, and the TTM maps 
were able to help better understand the drug release profiles from the microsphere 
formulations. 
5. Conclusions 
In conclusion, TTM is a novel thermal and imaging technique that can be applied 
to study the spatial drug distribution of as single microspheres in relation to their in 
vitro drug release performance, especially for formulations consisting of components 
with significantly different thermal properties. By using TTM in combination with 
other techniques such as XRD, FTIR and MTDSC, the physical and chemical 
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properties of microspheres could be understood more comprehensively as the 
different techniques complement each other.   
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